Aspirin may reduce risk for hepatocellular carcinoma, liver-related mortality in chronic viral hepatitis

Low-dose aspirin use appeared associated with significantly lower risk for hepatocellular carcinoma and lower liver-related mortality among patients with chronic viral hepatitis, according to results of a retrospective study published in The New England Journal of Medicine.Moreover, low-dose aspirin did not significantly increase risk for gastrointestinal bleeding in this patient population.“There is growing evidence that aspirin may offer unique benefits for patients with liver disease,” Tracey Simon, MD, MPH, hepatologist in the division of gastroenterology and instructor ofRead More

Share on facebook
Share on twitter
Share on linkedin